ReviewNPJ Regenerative medicine2018

Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions.

Claire Horner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.